Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Facilitation of Osteoblast Differentiation by ATF-4 Accumulation through Proteasome Inhibition.

Shingen Nakamura, Masahiro Abe, Qu Cui, Ayako Nakano, Asuka Oda, Hiroe Amou, Akishige Ikegame, Takeshi Harada, Masahiro Hiasa, Hirokazu Miki, Kumiko Kagawa, Kyoko Takeuchi, Kenichiro Yata, Shuji Ozaki, Toshio Matsumoto

Blood (2009) 114 (22): 1823.

https://doi.org/10.1182/blood.V114.22.1823.1823

Published: 2009

Journal Articles

A Recombinant HLA Class I-Specific Single-Chain Fv Diabody Can Target Cancer Stem Cell-Like Side Population Cells in Multiple Myeloma.

Akishige Ikegame, Shuji Ozaki, Daisuke Tsuji, Takeshi Harada, Shingen Nakamura, Hirokazu Miki, Ayako Nakano, Kumiko Kagawa, Kyoko Takeuchi, Kenichiro Yata, Masahiro Abe, Kohji Itoh, Toshio Matsumoto

Blood (2009) 114 (22): 2799.

https://doi.org/10.1182/blood.V114.22.2799.2799

Published: 2009

Journal Articles

GM-CSF and IL-4 induce dendritic cell differentiation and disrupt osteoclastogenesis through M-CSF receptor shedding by up-regulation of TNF-α converting enzyme (TACE)

Masahiro Hiasa, Masahiro Abe, Ayako Nakano, Asuka Oda, Hiroe Amou, Shinsuke Kido, Kyoko Takeuchi, Kumiko Kagawa, Kenichiro Yata, Toshihiro Hashimoto, Shuji Ozaki, Kenzo Asaoka, Eiji Tanaka, Keiji Moriyama, Toshio Matsumoto

Blood (2009) 114 (20): 4517–4526.

https://doi.org/10.1182/blood-2009-04-215020

Published: 2009

Includes: Supplemental data

Journal Articles

Anti-Myeloma Effects of γδ T Cells Are Hampered by Bone Marrow Stromal Cells but Resumed by Stromal Cell-Derived Osteoblasts.

Kenichiro Yata, Masahiro Abe, Asuka Oda, Hiroe Amou, Masahiro Hiasa, Kyoko Takeuchi, Shingen Nakamura, Osamu Tanaka, Hirokazu Miki, Ayako Nakano, Kumiko Kagawa, Shuji Ozaki, Toshio Matsumoto

Blood (2008) 112 (11): 1685.

https://doi.org/10.1182/blood.V112.11.1685.1685

Published: 2008

Journal Articles

KRN5500, a Spicamycin Derivative, Exerts Anti-Myeloma Effects through Impairing Both Myeloma Cells and Osteoclasts.

Hirokazu Miki, Shuji Ozaki, Osamu Tanaka, Shingen Nakamura, Ayako Nakano, Kumiko Kagawa, Kyoko Takeuchi, Kenichiro Yata, Masahiro Abe, Toshio Matsumoto

Blood (2008) 112 (11): 1669.

https://doi.org/10.1182/blood.V112.11.1669.1669

Published: 2008

Journal Articles

The Serine/Threonine Kinase Pim-2 Is a Novel Anti-Apoptotic Mediator in Myeloma Cells.

Jin Asano, MD, Masahiro Abe, MD, Shiro Fujii, MD, Osamu Tanaka, MD, Ai Mihara, MD, Shingen Nakamura, MD, Kazuhiro Miki, MD, Kumiko Kagawa, MD, Kyoko Takeuchi, MD, Kenichiro Yata, MD, Toshihiro Hashimoto, MD, Shuji Ozaki, MD, Masahiro Hiasa, DDS, Toshio Matsumoto, MD

Blood (2007) 110 (11): 243.

https://doi.org/10.1182/blood.V110.11.243.243

Published: 2007

Journal Articles

Inhibition of TACE Activity Enhances the Susceptibility of Myeloma Cells to TRAIL.

Kumiko Kagawa, MD, Masahiro Abe, MD, Shiro Fujii, MD, Osamu Tanaka, MD, Ai Mihara, MD, Shingen Nakamura, MD, Kazuhiro Miki, MD, Jin Asano, MD, Kyoko Takeuchi, MD, Kenichiro Yata, MD, Toshihiro Hashimoto, MD, Shuji Ozaki, MD, Masahiro Hiasa, DDS, Toshio Matsumoto, MD

Blood (2007) 110 (11): 244.

https://doi.org/10.1182/blood.V110.11.244.244

Published: 2007

Journal Articles

Combination of a Spicamycin Analogue KRN5500 and Chemotherapeutic Agents Synergistically Enhances Their Cytotoxicity in Human Myeloma Cells.

Hirokazu Miki, MD, Shuji Ozaki, MD, Osamu Tanaka, MD, Shiro Fujii, MD, Shingen Nakamura, MD, Ai Mihara, MD, Kumiko Kagawa, MD, Jin Asano, MD, Kyoko Takeuchi, MD, Kenichiro Yata, MD, Toshihiro Hashimoto, MD, Masahiro Abe, MD, Toshio Matsumoto, MD

Blood (2007) 110 (11): 4783.

https://doi.org/10.1182/blood.V110.11.4783.4783

Published: 2007

Journal Articles

Systemic Treatment with the Antiangiogenic Agent ABT-510 Inhibited Myeloma-Induced Microvessels and Tumor Growth in Myelomatous SCID-hu Mice.

Shmuel Yaccoby, PhD, Wen Ling, Rinku Saha, Kenichiro Yata, MD, Guido Tricot, MD

Blood (2005) 106 (11): 3451.

https://doi.org/10.1182/blood.V106.11.3451.3451

Published: 2005

Journal Articles

The Plasticity of Myeloma Plasma Cells as Expressed by Dedifferentiation into an Immature, Resilient, Apoptosis-Resistant Phenotype.

Shmuel Yaccoby, PhD, Kenichiro Yata, MD, Yun Ge, PhD, Bart Barlogie, MD, PhD, Guido Tricot, MD, Joshua Epstein, DSc

Blood (2004) 104 (11): 633.

https://doi.org/10.1182/blood.V104.11.633.633

Published: 2004

Journal Articles

Role of Osteoclasts in Regulation of Human Hematopoietic Stem Cell Niche and Fate.

Shmuel Yaccoby, PhD, Kenichiro Yata, MD, Yun Ge, PhD, Bart Barlogie, MD, PhD, Joshua Epstein, DSc, Guido Tricot, MD

Blood (2004) 104 (11): 4253.

https://doi.org/10.1182/blood.V104.11.4253.4253

Published: 2004

NARROW

Facilitation of Osteoblast Differentiation by ATF-4 Accumulation through Proteasome Inhibition.

A Recombinant HLA Class I-Specific Single-Chain Fv Diabody Can Target Cancer Stem Cell-Like Side Population Cells in Multiple Myeloma.

GM-CSF and IL-4 induce dendritic cell differentiation and disrupt osteoclastogenesis through M-CSF receptor shedding by up-regulation of TNF-α converting enzyme (TACE)

Anti-Myeloma Effects of γδ T Cells Are Hampered by Bone Marrow Stromal Cells but Resumed by Stromal Cell-Derived Osteoblasts.

KRN5500, a Spicamycin Derivative, Exerts Anti-Myeloma Effects through Impairing Both Myeloma Cells and Osteoclasts.

The Serine/Threonine Kinase Pim-2 Is a Novel Anti-Apoptotic Mediator in Myeloma Cells.

Inhibition of TACE Activity Enhances the Susceptibility of Myeloma Cells to TRAIL.

Combination of a Spicamycin Analogue KRN5500 and Chemotherapeutic Agents Synergistically Enhances Their Cytotoxicity in Human Myeloma Cells.

Systemic Treatment with the Antiangiogenic Agent ABT-510 Inhibited Myeloma-Induced Microvessels and Tumor Growth in Myelomatous SCID-hu Mice.

The Plasticity of Myeloma Plasma Cells as Expressed by Dedifferentiation into an Immature, Resilient, Apoptosis-Resistant Phenotype.

Role of Osteoclasts in Regulation of Human Hematopoietic Stem Cell Niche and Fate.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only